3 Results for "

BMX-IN-4

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BMX-IN-4" in MCE Product Catalog:

Cat. No.: HY-187351
CAS No.: 3132799-96-0
Target:  

BMX Kinase

Research Areas:  

Cancer

BMX-IN-4 is a covalent BMX kinase inhibitor with an IC50 of 1.78 nM and a Ki of 0.158 μM. BMX-IN-4 forms a covalent bond with BMX kinase. BMX-IN-4 is applicable to the research of hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-111553
CAS No.: 2088323-16-2
Purity:  99.71%
Target:  

EGFR

Research Areas:  

Cancer

TAS0728 is a potent, selective, orally active, irreversible and covalent-binding HER2 inhibitor, with an IC50 of 13 nM. TAS0728 also shows IC50s of 4.9, 8.5, 31, 65, 33, 25 and 86 nM for BMXHER4BLK、EGFR、JAK3SLK and LOK respectively. Furthermore, TAS0728 exhibits robust and sustained inhibition of the phosphorylation of HER2, HER3, and downstream effectors .
loading...
    loading...
Cat. No.: HY-111553R
CAS No.: 2088323-16-2
Research Areas:  

Cancer

TAS0728 (Standard) is the analytical standard of TAS0728 (HY-111553). This product is intended for research and analytical applications. TAS0728 is a potent, selective, orally active, irreversible and covalent-binding HER2 inhibitor, with an IC50 of 13 nM. TAS0728 also shows IC50s of 4.9, 8.5, 31, 65, 33, 25 and 86 nM for BMX、HER4、BLK、EGFR、JAK3、SLK and LOK respectively. Furthermore, TAS0728 exhibits robust and sustained inhibition of the phosphorylation of HER2, HER3, and downstream effectors .
loading...
    loading...